The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background and Objectives
COVID‐19 convalescent plasma (CCP) has retained potency and clinical efficacy against SARS‐CoV‐2 and is currently of utmost value for seronegative immunocompromised patients. Since most of the effect is due to the vaccine boost of infection‐elicited antibodies, there is a theoretical concern that the frequency of suitable donors is declining.
Materials and Methods
In this...
Information on the immune response during the mpox virus (MPXV) infection is still scarce or limited to past studies when cross‐reactive immunity from smallpox vaccination was predominant. Here, we describe the short‐term kinetics of the antibody response in patients with acute MPXV infection during the 2022 multicountry outbreak. A total of 64 samples from 18 MPXV‐positive patients were longitudinally...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.